H.R. 653, the "Protect Minors from Medical Malpractice Act of 2025," creates a federal private right of action for individuals who received a gender‑transition procedure before age 18. The bill authorizes lawsuits (brought by the individual or a representative) for physical, psychological, emotional, or physiological injury resulting from puberty blockers, cross‑sex hormones, or surgeries, and permits compensatory and punitive damages plus attorney’s fees.
The bill reaches these cases by listing a series of interstate‑commerce connections (travel, payments, communications, use of items that traveled in commerce, and territorial jurisdiction) to establish federal jurisdiction; it also includes a conscience clause protecting providers from being required to perform such procedures and a funding penalty that bars HHS funds to any State that mandates practitioners perform gender‑transition procedures. The statute takes effect on enactment and narrowly defines "biological sex" and exceptions for intersex conditions, emergency lifesaving care, and treatment of complications.
At a Glance
What It Does
Creates a federal civil cause of action for minors who received defined gender‑transition procedures before age 18 and permits suits up to 30 years after the individual turns 18. Establishes multiple interstate‑commerce criteria to ground federal jurisdiction, allows punitive damages and attorneys’ fees, and bars HHS funding to states that require practitioners to perform such procedures.
Who It Affects
Medical practitioners licensed by states who prescribe puberty blockers, cross‑sex hormones, or perform gender‑related surgery on minors; health systems and clinics offering pediatric gender‑affirming care; insurers and malpractice carriers covering those providers; and minors (and their legal representatives) who received such care.
Why It Matters
The bill converts certain pediatric gender‑related interventions into a new long‑tail federal malpractice exposure, potentially drawing routine medical‑licensure and standard‑of‑care disputes into federal courts via broad commerce hooks. It also couples liability exposure with conscience protections and federal funding penalties for states, shifting incentives for providers and state policy.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a federal private right of action for anyone injured by a "gender‑transition procedure" performed while they were a minor. "Injured" covers a broad set of harms (physical, psychological, emotional, physiological). Suits may be filed by the individual who received care or by a representative, and the claim period runs until 30 years after the individual turns 18 — a much longer exposure window than many state malpractice statutes.
Remedies expressly include declaratory or injunctive relief, compensatory and punitive damages, and attorney’s fees and costs.
To ensure these claims can be brought in federal court, the statute lists several circumstances that create federal jurisdiction: if the provider or patient traveled in interstate or foreign commerce in connection with the procedure; if the provider used interstate channels (including telemedicine, payments, or mail); if items used in the procedure traveled in interstate commerce; if communications occurred across state lines; or if the conduct affected interstate commerce generally. That language is expansive and reaches common cross‑state interactions — telehealth consults, out‑of‑state travel for care, or use of pharmaceuticals distributed across state lines.The bill defines "gender‑transition procedure" to include puberty‑blocking drugs, cross‑sex hormones, and surgeries intended to align a minor’s body with their subjective gender identity, while carving out three exceptions: individuals born with inherently ambiguous sex characteristics (as described), interventions necessary to treat complications or infections caused by such procedures, and emergency procedures required to prevent imminent death or major bodily impairment.
The statute also defines "biological sex" in genetic and anatomical terms, expressly excluding subjective identity.Separate provisions state that no federal law shall be construed to require a medical practitioner to perform a gender‑transition procedure (a conscience protection), and that any State that requires practitioners to perform such procedures is ineligible for HHS funding. The act takes effect on enactment, meaning any ongoing or future care after that date could give rise to claims under the new federal cause of action.
The Five Things You Need to Know
The bill gives a private right of action for minors (or their representatives) injured by a gender‑transition procedure and allows suits through the later of 30 years after the plaintiff turns 18.
Remedies available include declaratory or injunctive relief, compensatory and punitive damages, plus attorneys’ fees and costs.
The statute defines gender‑transition procedures to cover puberty blockers, cross‑sex hormones, and surgical interventions, but excludes interventions for people with certain intersex conditions, emergency lifesaving care, and treatment for complications or infections arising from such interventions.
Federal jurisdiction is drawn broadly via interstate‑commerce hooks: travel, communications (including electronic), payments, use of items that traveled in commerce, territorial jurisdiction, or any effect on interstate commerce.
The bill bars any federal requirement forcing practitioners to perform gender‑transition procedures (conscience protection) and makes a State that requires such procedures ineligible for HHS funding.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Sets the act's short title as the "Protect Minors from Medical Malpractice Act of 2025." This is purely stylistic but signals the sponsor's framing and guides citation.
Federal private cause of action and remedies
Creates the federal private cause of action for individuals injured by gender‑transition procedures performed while under 18. It specifies the scope of recoverable harms (physical, psychological, emotional, physiological) and the available relief (declaratory/injunctive, compensatory, punitive damages, and attorney’s fees). Practically, this provision converts what is typically a state malpractice claim into a federal civil claim when the jurisdictional predicates in subsection (c) apply.
Interstate‑commerce jurisdictional predicates
Lists seven alternative bases for federal jurisdiction: travel by provider or patient, use of interstate channels, payments across state lines, interstate communications, use of items that traveled in commerce, conduct within U.S. special maritime or territorial jurisdiction, or any conduct affecting interstate or foreign commerce. Each listed item is an independent hook, making it relatively easy for plaintiffs to satisfy federal jurisdiction in many common scenarios, such as telemedicine consults, out‑of‑state care, or use of pharmaceuticals.
Conscience protection for medical practitioners
Declares that no federal law shall be construed to require a medical practitioner to perform a gender‑transition procedure. Operationally, this provision affirms that practitioners cannot be compelled under federal law, but it does not create a private right of action for a provider denied the ability to perform a procedure nor does it specify disciplinary or enforcement mechanisms. It also does not limit state laws that might require such procedures.
HHS funding prohibition for states that require procedures
Makes any State that "requires medical practitioners to perform any gender‑transition procedure" ineligible for HHS funds. This is a conditional federal funding penalty; the statute does not define the mechanics for HHS enforcement, appeal, or how narrowly a state law must "require" a practitioner to perform a procedure to trigger ineligibility. The provision creates a fiscal lever that could influence state policy but raises administrative and legal questions about scope and process.
Definitions and effective date
Provides operative definitions: "biological sex" tied to chromosomes, hormones, and genitalia at birth; "gender‑transition procedure" enumerated as puberty blockers, cross‑sex hormones, and surgery, plus a set of explicit exceptions for intersex conditions, treatment of complications, and emergency lifesaving care. Section 6 makes the act effective upon enactment, meaning the new cause of action and funding rules apply immediately going forward.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Individuals who received gender‑transition procedures as minors — they gain a federal cause of action and a long limitations window (until 30 years after turning 18) to bring claims for a wide range of harms.
- Plaintiffs’ attorneys — expanded federal jurisdiction and an extended filing window create new case volume and fee opportunities under the statute’s fee‑shifting language.
- Medical practitioners and organizations opposing such procedures — they gain an explicit federal conscience protection that can be cited in institutional policies and provider decision‑making.
- States that restrict or ban these procedures — the HHS funding provision strengthens federal leverage against states that require such care, aligning federal incentives with state prohibitions.
Who Bears the Cost
- Medical practitioners and clinics that provide pediatric gender‑related interventions — they face increased litigation risk, potential punitive damages, and longer‑tail liability exposure, which could raise malpractice premiums or cause providers to stop offering these services.
- Malpractice insurers and health systems — insurers may face higher claims or deny coverage for certain interventions, and health systems may incur compliance, legal, and defense costs.
- Minors seeking gender‑affirming care and their families — potential chilling of service availability and longer access pathways if providers curtail pediatric offerings in response to liability or funding risks.
- State governments that require or mandate provision of such procedures — they risk loss of HHS funding if their statutes or policies are interpreted as obligating practitioners to perform the procedures.
Key Issues
The Core Tension
The bill poses a classic trade‑off: it aims to protect minors by creating a strong federal remedy against certain pediatric interventions, but does so by expanding federal jurisdiction and long‑term liability in an area traditionally governed by medical judgment and state malpractice law — a move that may improve accountability for some while chilling clinical practice, complicating care access, and generating federal‑state legal conflict.
The bill creates implementation challenges and legal friction points. The interstate‑commerce list is broad; commonplace elements of medical care — telehealth visits, prescriptions filled from national distributors, patient travel to another state, or routine electronic communications — may bring otherwise local malpractice disputes into federal court.
That federalization changes procedural rules, may shift venue patterns, and could invite challenges on grounds of federalism if states view malpractice as a matter of state law.
The 30‑year post‑majority filing window creates long‑tail exposure that affects record retention, underwriting by insurers, and institutional risk management. Insurers and providers will need clarity on whether past treatments (before enactment) are covered, how retroactivity is handled, and whether state statutes of repose remain operative.
The bill’s definitions create clinical‑legal tension: tying "biological sex" to chromosomes and anatomy while excluding subjective identity can conflict with current medical guidelines that emphasize individualized assessment, and the intersex exception hinges on specific genetic/biochemical findings that may not be routinely documented.
Finally, the HHS funding prohibition lacks procedural detail: it does not define how HHS determines a State "requires" a practitioner to perform a procedure, what remedies or notice processes apply, or how this interacts with other federal spending conditions. That ambiguity invites litigation and could produce uneven enforcement across administrations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.